Showing results (161-170 of 231) with videos related to

Sort By:
Pageof 24
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2016
Molecular Profiling to Determine Clonality of Serial Magnetic Resonance Imaging/Ultrasound Fusion Biopsies from Men on Active Surveillance for Low-Risk Prostate CancerGanesh S Palapattu, Simpa S Salami, Andi K Cani, et al.
Neoplasia (New York, N.Y.)|July 24, 2010
Antibody-based detection of ERG rearrangement-positive prostate cancerKyung Park, Scott A Tomlins, Kumaran M Mudaliar, et al.
Urology|August 11, 2020
Impact of the MyProstateScore (MPS) Test on the Clinical Decision to Undergo Prostate Biopsy: Results From a Contemporary Academic PracticeAmir H Lebastchi, Christopher M Russell, Yashar S Niknafs, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 21, 2019
Next-generation sequencing implicates oncogenic roles for p53 and JAK/STAT signaling in microcystic adnexal carcinomasMay P Chan, Komal R Plouffe, Chia-Jen Liu, et al.
The Journal of Urology|February 28, 2016
Prognostic Value of Percent Gleason Grade 4 at Prostate Biopsy in Predicting Prostatectomy Pathology and RecurrenceAdam I Cole, Todd M Morgan, Daniel E Spratt, et al.
Molecular Cancer Research : MCR|January 17, 2015
Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes TumorsAndi K Cani, Daniel H Hovelson, Andrew S McDaniel, et al.
JCO Precision Oncology|February 15, 2019
Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate CancerDeli Liu, Mandeep Takhar, Mohammed Alshalalfa, et al.
Nature|August 3, 2007
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancerScott A Tomlins, Bharathi Laxman, Saravana M Dhanasekaran, et al.
European Urology|May 13, 2015
Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypesScott A Tomlins, Mohammed Alshalalfa, Elai Davicioni, et al.
Nature Medicine|February 9, 2016
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancerHimisha Beltran, Davide Prandi, Juan Miguel Mosquera, et al.
Pageof 24